Cigna Reports Strong Q1 Earnings, Raises 2025 Guidance

Cigna reported strong first-quarter earnings, surpassing analyst expectations with an EPS of $6.74 and revenue of $65.5 billion, reflecting a 14% year-over-year increase. Growth was driven by successful execution in its Evernorth Health Services and Cigna Healthcare segments, with significant gains in specialty pharmacy services and premium rate increases. The company raised its full-year 2025 guidance, projecting adjusted earnings from operations of at least $29.60 per share, and announced the strategic divestiture of its Medicare businesses to focus on high-growth segments. Analyst sentiment remains positive, with an average one-year price target of $359.83 and a consensus 'Outperform' rating from 26 brokerage firms. Cigna’s customer base has grown steadily, while revenue per customer has increased, indicating enhanced value delivery. Long-term and recent growth trends suggest ongoing momentum for the company in the healthcare sector.